LONG-TERM IMPACT OF GRASS-POLLEN (GP) SUBLINGUAL IMMUNOTHERAPY TABLET (SLIT) ON ALLERGIC RHINITIS (AR) AND ON ALLERGIC ASTHMA (AA) ONSET AND PROGRESSION

Author(s)

Devillier P1, Molimard M2, Demoly P3, Ansolabehere X4, Bardoulat I5, Coulombel N5, Maurel F6, Le Jeunne P5
1UPRES EA220, Hôpital Foch, Suresnes, France, 2CHU of Bordeaux University, Bordeaux, France, 3Department of Pulmonology, Montpellier, France, 4QuintilesIMS, Paris La Défense, France, 5QuintilesIMS, Paris La Défense 2, France, 6QuintilesIMS, La Défense Cedex, France

OBJECTIVES: To assess the long-term effectiveness of grass-pollen (GP) sublingual immunotherapy (SLIT) tablet on allergic rhinitis (AR) and asthma in France.

METHODS: A retrospective analysis using real-world data from IMS Longitudinal Prescriptions (LRx), a database including one-third of French retail pharmacies was performed over 4.8 years (March

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PRS2

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Respiratory-Related Disorders

Explore Related HEOR by Topic

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×